A disease‐specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: Results of a randomized, controlled, multicenter trial
Rainer Fietkau(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dorota Łubgan(Universitätsklinikum Erlangen), Marcus Niewald(Saarland University), Claus Rödel(Goethe University Frankfurt), Thomas Kuhnt(Leipzig University), Victor Lewitzki(Universitätsklinikum Würzburg), Bernhard Berger(Universität Hamburg), Robert Michael Hermann(Providence Portland Medical Center), Tobias Hölscher(University Hospital Carl Gustav Carus), C.F. Hess(University of Göttingen), Thomas Wiegel(University Hospital Ulm)
Cited by 84
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
|Journal of Clinical Oncology|2011|609
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
|European Urology|2021|298